Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svrcek

Showing results (161-170 of 299) with videos related to

Pageof 30
Sort By:
British Journal of Cancer|July 23, 2013
Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancerN Chaput, M Svrcek, A Aupérin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 20, 2003
COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomasDominique Wendum, Magali Svrcek, Valérie Rigau, et al.
The American Journal of Gastroenterology|June 17, 2010
Risk factors for neoplasia in inflammatory bowel disease patients with pancolitisVivianne Bergeron, Ariane Vienne, Harry Sokol, et al.
Current Oncology Reports|February 11, 2016
New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal CancerRomain Cohen, Magali Svrcek, Chantal Dreyer, et al.
Familial Cancer|September 19, 2012
Somatic mosaicism and double somatic hits can lead to MSI colorectal tumorsIsabelle Sourrouille, Florence Coulet, Jeremie H Lefevre, et al.
Clinics and Research in Hepatology and Gastroenterology|March 6, 2023
Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinomaL Mas, J Cros, M Svrcek, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 13, 2018
Prognostic value and characteristics of N1c colorectal cancerM Bouquot, B Creavin, N Goasguen, et al.
Clinical Genetics|April 12, 2011
Unexplained polyposis: a challenge for geneticists, pathologists and gastroenterologistsC Mongin, F Coulet, J H Lefevre, et al.
Virchows Archiv : an International Journal of Pathology|August 7, 2007
Small intestinal CD4+ T-cell lymphoma: a rare distinctive clinicopathological entity associated with prolonged survivalMagali Svrcek, Laurent Garderet, Virginie Sebbagh, et al.
Clinical Colorectal Cancer|June 9, 2024
Survival Outcomes in Patients with Monobloc-Resected Stage IIC (pT4bN0) Colon Cancer: A Retrospective Observational Cohort StudyJuliette Logeart, Thomas Samaille, Antoine Falcoz, et al.
Pageof 30

Showing results (161-170 of 299) with videos related to

Sort By:
Pageof 30
British Journal of Cancer|July 23, 2013
Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancerN Chaput, M Svrcek, A Aupérin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 20, 2003
COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomasDominique Wendum, Magali Svrcek, Valérie Rigau, et al.
The American Journal of Gastroenterology|June 17, 2010
Risk factors for neoplasia in inflammatory bowel disease patients with pancolitisVivianne Bergeron, Ariane Vienne, Harry Sokol, et al.
Current Oncology Reports|February 11, 2016
New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal CancerRomain Cohen, Magali Svrcek, Chantal Dreyer, et al.
Familial Cancer|September 19, 2012
Somatic mosaicism and double somatic hits can lead to MSI colorectal tumorsIsabelle Sourrouille, Florence Coulet, Jeremie H Lefevre, et al.
Clinics and Research in Hepatology and Gastroenterology|March 6, 2023
Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinomaL Mas, J Cros, M Svrcek, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 13, 2018
Prognostic value and characteristics of N1c colorectal cancerM Bouquot, B Creavin, N Goasguen, et al.
Clinical Genetics|April 12, 2011
Unexplained polyposis: a challenge for geneticists, pathologists and gastroenterologistsC Mongin, F Coulet, J H Lefevre, et al.
Virchows Archiv : an International Journal of Pathology|August 7, 2007
Small intestinal CD4+ T-cell lymphoma: a rare distinctive clinicopathological entity associated with prolonged survivalMagali Svrcek, Laurent Garderet, Virginie Sebbagh, et al.
Clinical Colorectal Cancer|June 9, 2024
Survival Outcomes in Patients with Monobloc-Resected Stage IIC (pT4bN0) Colon Cancer: A Retrospective Observational Cohort StudyJuliette Logeart, Thomas Samaille, Antoine Falcoz, et al.
Pageof 30